N
ZBH icon

Nuveen’s Zimmer Biomet ZBH Stock Holding History

Nuveen’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-26,265
Closed -$3K – 3373
2020
Q3 		$3K Hold
26,265
– – ﹤0.01% 3282
2020
Q2 		$3K Buy
+26,265
New +$3.03M ﹤0.01% 3247

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen's ZBH Position: Q1 2026 in Review

Nuveen reduced its Zimmer Biomet (ZBH) stake by 10% in Q1 2026, selling an estimated $10.7M and leaving 999,912 shares worth $90.4M. The position accounts for 0.02% of the portfolio, ranked #424.

Nuveen first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $671M in Q4 2020. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Nuveen held 999,912 shares of Zimmer Biomet worth $90.4M as of Q1 2026.
  • Nuveen sold 116,413 Zimmer Biomet shares in Q1 2026, an estimated $10.7M.
  • Zimmer Biomet made up 0.02% of Nuveen's portfolio in Q1 2026, its #424 holding.
  • Nuveen first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Nuveen's Zimmer Biomet position peaked at $671M in Q4 2020.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.